DEBT (Details)
$ / shares in Units, $ in Thousands |
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
|
|
|
Dec. 18, 2020
USD ($)
$ / shares
|
Nov. 09, 2020
USD ($)
shares
|
May 03, 2019
USD ($)
$ / shares
shares
|
Jan. 31, 2021
EUR (€)
|
Dec. 18, 2020
USD ($)
$ / shares
|
Nov. 30, 2020
USD ($)
$ / shares
shares
|
Oct. 31, 2020
USD ($)
$ / shares
|
Aug. 31, 2020
USD ($)
$ / shares
shares
|
Jul. 31, 2020
USD ($)
$ / shares
|
Sep. 30, 2019 |
Aug. 31, 2019
USD ($)
$ / shares
shares
|
Apr. 30, 2019
USD ($)
$ / shares
shares
|
Oct. 31, 2018
USD ($)
shares
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2020
USD ($)
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2020
USD ($)
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2019
USD ($)
|
Jan. 01, 2021 |
Dec. 17, 2020
$ / shares
|
Mar. 31, 2020 |
Mar. 31, 2019
USD ($)
$ / shares
shares
|
Dec. 31, 2018
USD ($)
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt issuance costs, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 741
|
|
$ 1,183
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
$ 3,000
|
|
|
|
|
|
|
$ 4,162
|
|
|
|
|
$ 483
|
$ 741
|
$ 483
|
$ 741
|
|
|
|
|
|
|
|
|
| Aggregate gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of conversion price |
|
|
|
|
|
|
|
|
|
|
30.00%
|
|
|
20.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liability, redemption feature probability |
|
|
|
|
|
|
|
|
|
|
|
|
|
80.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Embedded derivative, carrying value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on debt extinguishment |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,360)
|
|
(3,374)
|
|
|
|
|
|
| Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,678
|
|
33,678
|
|
33,843
|
|
33,728
|
|
|
|
|
|
| Convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,142
|
[2] |
26,566
|
|
|
|
|
|
| Option, equity financing, pro rata share of total securities issued |
|
25.00%
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,559
|
|
6,559
|
|
$ 6,701
|
|
7,162
|
|
|
|
|
|
| Strike price (in Dollars per share) | $ / shares |
|
$ 13.00
|
|
|
|
$ 13.00
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8.90
|
|
|
|
|
|
|
|
| Loss on fair value of derivative instrument |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13)
|
|
|
$ 657
|
[2] |
421
|
|
|
|
|
|
| Neem Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Portugal Line of Credit [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Borrowing amount (in Euro) | € |
|
|
|
|
€ 1,000,000.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repayment of principal amount (in Euro) | € |
|
|
|
|
€ 62,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Debentures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, qualified financing, gross proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D Convertible Notes Due March 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly interest, satisfaction of payment through issued of common stock, percentage |
|
95.00%
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D Convertible Notes Due March 2022 | Series C Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 30,258
|
|
| Series D Convertible Notes Due March 2022 | Series D convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,750
|
|
| September 2023 Convertible Debentures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
$ 1,230
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative instrument liability |
|
|
|
|
|
|
|
$ 570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liability, redemption feature probability |
|
|
|
|
|
|
|
43.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Embedded derivative, carrying value |
|
|
|
|
|
|
|
$ 2,160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on debt extinguishment |
|
|
|
|
|
|
|
$ 570
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Election to convert accrued and unpaid interest to common stock (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
$ 5.95
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued and unpaid interest to common stock, redemption feature |
|
|
|
|
|
|
|
70.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on fair value of derivative instrument |
|
|
|
|
|
|
|
$ 600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| September 2023 Convertible Debentures | Clever Leaves |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
$ 2,730
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| September 2023 Convertible Debentures | Class A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
$ 2.303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly interest, satisfaction of payment through issued of common stock, percentage |
|
95.00%
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D Convertible Notes due March 2022 [Member] | Series C Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,258
|
|
| Series C Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 18,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity date |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative instrument liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,900
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series C Financing | Series C Convertible Debentures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative instrument liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,400
|
| Series D Financing [Member] | Series C Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Embedded derivative, carrying value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,475
|
|
|
|
|
|
| Conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17,890
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,546,670
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense, debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300
|
|
|
|
|
|
| Loss on debt extinguishment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,374
|
|
|
|
|
|
| Embedded derivative, loss on embedded derivative |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
133
|
|
|
|
|
|
| Series D Financing [Member] | Series D Convertible Notes Due March 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 27,750
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
8.00%
|
|
| Common stock shares, guaranteed and secured (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,300,002
|
|
| Convertible, common shares, minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
$ 30.62
|
|
|
|
$ 30.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11
|
|
$ 11
|
|
| Share price, trigger event (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.54
|
|
| Series D Financing [Member] | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 27,750
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
8.00%
|
|
| Common stock shares, guaranteed and secured (in Shares) | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,300,002
|
|
| Convertible, common shares, minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11.00
|
|
| Share price, trigger event (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.54
|
|
| Series D Financing [Member] | Minimum [Member] | Series D Convertible Notes Due March 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price, trigger event (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.54
|
|
| Series D Financing [Member] | Minimum [Member] | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price, trigger event (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13.54
|
|
| Convertible Note 2022 Amendment Member | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prepayment option, interest payments |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prepayment option remaining balance of loan |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Note 2022 Amendment Member | Series D Convertible Notes Due March 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
8.00%
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly interest, satisfaction of payment through issued of common stock, percentage |
|
95.00%
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Option, equity financing, pro rata share of total securities issued |
|
25.00%
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Note 2022 Amendment Member | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Option, equity financing, pro rata share of total securities issued |
|
25.00%
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Note 2022 Amendment Member | Convertible Note 2022 Amendment Member |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly interest, satisfaction of payment through issued of common stock, percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.00%
|
|
|
|
|
| Convertible Note 2022 Amendment Member | Maximum [Member] | Series D Convertible Notes Due March 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Periodic payment, interest |
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Note 2022 Amendment Member | Maximum [Member] | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Periodic payment, interest |
|
|
|
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Herbal Brands Loan, non-revolving [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt issuance costs, net |
|
|
|
|
|
|
|
|
$ 400
|
|
|
$ 400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest expense, debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
188
|
154
|
390
|
310
|
704
|
|
456
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of repayment of positive operating cash flow |
|
|
|
|
|
|
|
|
|
|
|
|
85.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prepayment option, interest payments |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,338
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Incremental interest rate |
|
|
|
|
|
|
|
|
4.00%
|
|
|
4.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repayments of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,107
|
$ 429
|
1,191
|
|
$ 622
|
|
|
|
|
|
| Herbal Brands Loan, non-revolving [Member] | Minimum [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repayments of debt, expected to be paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000
|
|
|
|
|
|
|
|
| Herbal Brands Loan, non-revolving [Member] | Maximum [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repayments of debt, expected to be paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,300
|
|
|
|
|
|
|
|
| Series E Financing | Series E Convertible Debenture |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt issuance costs, net |
|
|
|
|
|
|
|
|
|
181
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
|
|
|
|
|
|
|
4,162
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative instrument liability |
|
|
|
|
|
|
|
|
|
$ 1,705
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Derivative liability, redemption feature probability |
|
|
|
|
|
|
|
|
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Embedded derivative, carrying value |
|
|
|
|
|
|
|
|
|
$ 2,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on debt extinguishment |
|
|
|
|
|
|
|
|
|
$ 1,705
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.0800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Election to convert accrued and unpaid interest to common stock (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 5.95
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accrued and unpaid interest to common stock, redemption feature |
|
|
|
|
|
|
|
|
|
70.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage ownership following redemption feature |
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Future conversion price, discount, redemption feature |
|
|
|
|
|
|
|
|
|
30.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on fair value of derivative instrument |
|
|
|
|
|
|
|
|
|
$ 85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series E Financing | Series E Convertible Debenture | Class A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 2.303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
|
|
|
|
|
|
|
$ 5,950
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neem Holdings Convertible Note | Neem Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neem Holdings Convertible Note | Series D convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt, termination of business combination, issuance of preferred shares (in Shares) | shares |
|
|
194,805
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neem Holdings Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, face amount |
|
|
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in Shares) | shares |
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
$ 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Neem Holdings Warrants | Neem Holdings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
|
|
|
|
$ 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D convertible debt | Series D Convertible Notes due March 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 27,750
|
|
| Series D Convertible Notes due March 2022 [Member] | Minimum [Member] | Series D Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
$ 11.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series D Convertible Notes due March 2022 [Member] | Maximum [Member] | Series D Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible, conversion price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
$ 30.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Herbal Brands Loan, non-revolving [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repayments of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,107
|
$ 414
|
|
|
|
|
|
|
|
|
|
|
| Rock Cliff [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
|
|
|
|
|
63,597
|
|
|
63,597
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Strike price (in Dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 26.73
|
|
|
$ 26.73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rock Cliff [Member] | Series C Preferred Stock [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, fair value |
|
|
|
$ 717
|
|
|
|
|
|
|
|
|
$ 717
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants or rights (in Shares) | shares |
|
|
|
193,402
|
|
|
|
|
|
|
|
|
193,402
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Strike price (in Dollars per share) | $ / shares |
|
|
|
$ 8.79
|
|
|
|
|
|
|
|
|
$ 8.79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rock Cliff [Member] | Warrant [Member] | Series C Preferred Stock [Member] | Herbal Brands, Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, fair value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 717
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loans and borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,783
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Investment in Public Equity (PIPE) | September 2023 Convertible Debentures | Schultze Special Purpose Acquisition Corp. (SAMA) | Clever Leaves |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DEBT (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment commitment |
|
|
|
|
|
|
$ 1,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|